Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - OTHER CURRENT LIABILITIES
Other Current Liabilities ELVN - Enliven Therapeutics, Inc.
25 M
LAST VALUE
185.38%
2 YEAR CAGR
93.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR